Related references
Note: Only part of the references are listed.Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
Pengcheng Han et al.
CELL (2022)
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Vikram Thakur et al.
INFECTION (2022)
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
Jiahui Chen et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)
OMICRON SUB-VARIANT: WHAT SCIENTISTS KNOW SO FAR
Ewen Callaway
NATURE (2022)
Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
Joseph Thomas Ortega et al.
PATHOGENS (2022)
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
Emi Takashita et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2
Leyun Wu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Spike mutation D614G alters SARS-CoV-2 fitness
Jessica A. Plante et al.
NATURE (2021)
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Erik Volz et al.
CELL (2021)
The role of Neuropilin-1 in COVID-19
Bindu S. Mayi et al.
PLOS PATHOGENS (2021)
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen et al.
NATURE MEDICINE (2021)
Dissecting the early COVID-19 cases in Wuhan
Michael Worobey
SCIENCE (2021)
Identifying New COVID-19 Receptor Neuropilin-1 in Severe Alzheimer's Disease Patients Group Brain Using Genome-Wide Association Study Approach
Key-Hwan Lim et al.
FRONTIERS IN GENETICS (2021)
Targeting neuropilins as a viable SARS-CoV-2 treatment
Sarvenaz Sarabipour et al.
FEBS JOURNAL (2021)
SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey et al.
NATURE REVIEWS MICROBIOLOGY (2021)
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
Frank Konings et al.
NATURE MICROBIOLOGY (2021)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The HDOCK server for integrated protein-protein docking
Yumeng Yan et al.
NATURE PROTOCOLS (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19
Julie Davies et al.
MOLECULAR MEDICINE REPORTS (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Neuropilin Functions as an Essential Cell Surface Receptor
Hou-Fu Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Tambet Teesalu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)